Principal Investigator: Eneda Toska, PhD
Eneda Toska, PhD
- University at Buffalo – PhD
- Memorial Sloan Kettering Cancer Center – Postdoctoral Fellowship
- Memorial Sloan Kettering Cancer Center – Senior Research Scientist
- K22 NCI Transition to Independence Award
- Innovation in Cancer Informatics
- Breast Cancer Research Alliance
- Jayne Koskinas Ted Giovanis Foundation for Health and Policy
- National Cancer Institute 1R21CA252530-01A1
- National Cancer Institute R01 R01CA276187
Eneda Toska, Ph.D., joined the Kimmel Cancer Center as an Assistant Professor of Oncology in the Cancer Invasion and Metastasis Program (CIM), in close collaboration with the Women’s Malignancies Disease Group. Eneda also was appointed to a secondary faculty position in the Bloomberg School of Public Health Department of Biochemistry and Molecular Biology (BMB), with membership in the BMB Ph.D. program. Eneda is also affiliated with the department of Pathobiology at the School of Medicine, the Convergence Institute, and the Epigenome Sciences Cluster.
Eneda graduated cum laude with a bachelor’s degree in Biology and Chemistry from Nazareth College of Rochester; received her master’s degree from the University at Buffalo, magna cum laude; and earned her doctorate from the University at Buffalo summa cum laude, completing her postdoctoral work with the late Dr. Jose Baselga at Memorial Sloan Kettering Cancer Center (MSKCC) and a senior research scientist role at MSKCC.
Dr. Toska has been awarded the Breast Cancer Research Alliance Young Investigator Award, a grant from the Jayne Koskinas Ted Giovanis Foundation for Health and Policy, a K22 Transition to Independence Award from the National Cancer Institute, a grant from the Innovation in Cancer Informatics, and has been selected as a 2021 AACR NextGen Star. Eneda also was the recipient of the 2023 AACR Cancer Research Early Career Award that awards early career investigators for their outstanding contributions to cancer research. Eneda frequently participates in NIH and NSF study sections, has served as chair of Epigenetics at the AACR 2022, and as an abstract reviewer for both the AACR and SABCS (San Antonio Breast Cancer Symposium). She also organizes multiple seminar series at Hopkins. Her work at Hopkins is studying the intersection of epigenetics and cell signaling. Her translational work focuses on endocrine therapy resistance in breast cancer.